GLP-1 (glucagon-like peptide 1) receptor agonist (semaglutide, Ozempic, Rybelsus, Wegovy) not only produce weight loss but also improve other metabolic variables, such as blood sugar, blood pressure, and lipids. Here, Dr. Rajnish Mago reviews how you might utilize GLP-1 receptor agonist to help manage antipsychotic-induced metabolic side effects.

You can enjoy the full lecture, titled “Balancing the Scales: Antipsychotic Side Effects”, here: https://nei.global/encore
Learn about upcoming NEI Meetings: https://nei.global/meetings

Stay updated with email alerts: https://nei.global/updates

Interested in Psychopharmacology? Check out the NEI Master Psychopharmacology Program: https://nei.global/mpp

Follow us on Facebook: https://nei.global/facebook
Follow us on LinkedIn: https://nei.global/linkedin
Follow us on X: https://nei.global/twitter
Follow us on Instagram: https://nei.global/instagram

🎙 Listen to NEI Podcast: https://nei.global/podcast

Copyright © Neuroscience Education Institute. All rights reserved.

0 Comments

Up next

Autoplay

✅Amitriptyline✅Elavil✅Endep✅ USES || SIDE EFFECTS || DOSAGE || INTERACTIONS #Amitriptyline#Elavil

0 Views . 08/29/25 Side Effects

Please note that if you are under 18, you won't be able to access this site.

Up next

GLP-1 Receptor Agonist & Metabolic Side Effects

Up next

Language